MODERATOR
:
Nora V. Hirschler, MD, CEO, Blood Centers of the Pacific
SPEAKER
(S):
Nora V. Hirschler, MD, CEO, Blood Centers of the Pacific
Kevin J. Land, MD, Chief Medical and Scientific Officer, Bonfils Blood Center
Platelet and Granulocyte Components, Further Processing, References
Ralph R. Vassallo, MD, FACP, Heritage Division Chief Medical Officer, American Red Cross Blood Services, Philadelphia, PA
What's New? Changes in the Circular of Information for the Use of Human Blood & Blood Components
Mark Fung, MD, PhD, Medical Director, Blood Bank and Transfusion Services, Fletcher Allen Health Care
Nora hirschler
Description
The Circular is an important extension to the blood component label which must be available to all medical personnel involved in transfusion processes. Members of the AABB Circular of Information Task Force will provide highlights of the significant changes since the July 2002 version, including incorporation of new testing language, more prominent discussions of TRALI and TACO, a reorganized plasma component section, an expanded further manufacturing section and many other additions and clarifications.
-
Describe the intended use of the Circular of Information for the Use of Human Blood and Blood Components.
-
Recognize important changes to the labeling of blood and blood components incorporated into the August 2009 version of the Circular.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.